Journal of Pain and Symptom Management
Volume 39, Issue 1 , Pages 88-99 , January 2010

A Randomized Clinical Trial of the Effectiveness of Photon Stimulation on Pain, Sensation, and Quality of Life in Patients With Diabetic Peripheral Neuropathy

  • Arthur Swislocki, MD

      Affiliations

    • Department of Medicine, Veterans Affairs Northern California Health Care System, Martinez, California, USA
    • ,
  • Marla Orth, MS, MPH

      Affiliations

    • Department of Medicine, Veterans Affairs Northern California Health Care System, Martinez, California, USA
    • ,
  • Maurice Bales, AA

      Affiliations

    • Department of Medicine, Veterans Affairs Northern California Health Care System, Martinez, California, USA
    • ,
  • Jennifer Weisshaupt, BA

      Affiliations

    • Department of Medicine, Veterans Affairs Northern California Health Care System, Martinez, California, USA
    • ,
  • Claudia West, RN, MS

      Affiliations

    • Department of Physiological Nursing, University of California, San Francisco, California, USA
    • ,
  • Janet Edrington, RN, PhD

      Affiliations

    • Department of Physiological Nursing, University of California, San Francisco, California, USA
    • ,
  • Bruce Cooper, PhD

      Affiliations

    • Department of Community Health Systems, University of California, San Francisco, California, USA
    • ,
  • Len Saputo, MD

      Affiliations

    • Health Medicine Institute, Lafayette, California, USA
    • ,
  • Melissa Islas, MD

      Affiliations

    • Department of Medicine, Veterans Affairs Northern California Health Care System, Martinez, California, USA
    • ,
  • Christine Miaskowski, RN, PhD, FAAN

      Affiliations

    • Department of Physiological Nursing, University of California, San Francisco, California, USA
    • Corresponding Author InformationAddress correspondence to: Christine Miaskowski, RN, PhD, Department of Physiological Nursing, University of California, 2 Koret Way—N631Y, San Francisco, CA 94143-0610, USA.

,Accepted 17 June 2009.

References 

  1. Sumpio BE. Foot ulcers. New Engl J Med. 2000;343:787–793
  2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–228
  3. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?. Diabetes Care. 1995;18:216–219
  4. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976–982
  5. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–1522
  6. Daousi C, Benbow SJ, Woodward A, MacFarlane IA. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med. 2006;23:1021–1024
  7. Vileikyte L, Leventhal H, Gonzalez JS. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005;28:2378–2383
  8. Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev. 2004;20(Suppl 1):S13–S18
  9. Benbow SJ, Wallymahmed ME, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM. 1998;91:733–737
  10. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain. 2006;22:681–685
  11. Gore M, Brandenburg NA, Dukes E, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005;30:374–385
  12. Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain. 2006;7:892–900
  13. Jensen TS, Backonja MM, Hernandez Jimenex S, et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res. 2006;3:108–119
  14. Jude EB, Schaper N. Treating painful diabetic polyneuropathy. BMJ. 2007;335(7610):57–58
  15. Varkonyi T, Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab. 2008;10:99–108
  16. Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007;335(7610):87
  17. Desmet KD, Paz DA, Corry JJ, et al. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg. 2006;24:121–128
  18. Pollett HF. Infrared light therapy in the treatment of chronic pain. Today's Ther Trends. 2002;20:357–371
  19. Whelan HT, Connelly JF, Hodgson BD, et al. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. J Clin Laser Med Surg. 2002;20:319–324
  20. Whelan HT, Smets RL, Buchman EV, et al. Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg. 2001;19:305–314
  21. Wong-Riley MT, Liang HL, Eells JT, et al. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem. 2005;280:4761–4771
  22. Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B. 1999;49:1–17
  23. Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed Laser Surg. 2005;23:355–361
  24. Karu TI, Pyatibrat LV, Afanasyeva NI. A novel mitochondrial signaling pathway activated by visible-to-near infrared radiation. Photochem Photobiol. 2004;80:366–372
  25. Tafur J, Mills PJ. Low-intensity light therapy: exploring the role of redox mechanisms. Photomed Laser Surg. 2008;26:323–328
  26. Rojas JC, Lee J, John JM, Gonzalez-Lima F. Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy. J Neurosci. 2008;28:13511–13521
  27. Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol. 2006;2:620–628
  28. Stirban A, Rosen P, Tschoepe D. Complications of type 1 diabetes: new molecular findings. Mt Sinai J Med. 2008;75:328–351
  29. Vanotti A, Osio M, Mailland E, et al. Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies. CNS Drugs. 2007;21(Suppl 1):3–12
  30. Harkless LB, DeLellis S, Carnegie DH, Burke TJ. Improved foot sensitivity and pain reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy—MIRE. J Diabetes Complications. 2006;20:81–87
  31. Kochman AB, Carnegie DH, Burke TJ. Symptomatic reversal of peripheral neuropathy in patients with diabetes. J Am Podiatr Med Assoc. 2002;92:125–130
  32. Powell MW, Carnegie DE, Burke TJ. Reversal of diabetic peripheral neuropathy and new wound incidence: the role of MIRE. Adv Skin Wound Care. 2004;17:295–300
  33. Clifft JK, Kasser RJ, Newton TS, Bush AJ. The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study. Diabetes Care. 2005;28:2896–2900
  34. Leonard DR, Farooqi MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment. Diabetes Care. 2004;27:168–172
  35. Lavery LA, Murdoch DP, Williams J, Lavery DC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care. 2008;31:316–321
  36. Zinman LH, Ngo M, Ng ET, et al. Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial. Diabetes Care. 2004;27:921–924
  37. Arnall DA, Nelson AG, Lopez L, et al. The restorative effects of pulsed infrared light therapy on significant loss of peripheral protective sensation in patients with long-term type 1 and type 2 diabetes mellitus. Acta Diabetol. 2006;43:26–33
  38. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108:477–481
  39. Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract. 2002;57:45–51
  40. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377–1384
  41. Downie WW, Leatham PA, Rhind VM, et al. Studies with pain rating scales. Ann Rheum Dis. 1978;37:378–381
  42. Lundeberg T, Lund I, Dahlin L, et al. Reliability and responsiveness of three different pain assessments. J Rehabil Med. 2001;33:279–283
  43. Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain. 2005;6:741–746
  44. Argoff CE, Galer BS, Jensen MP, et al. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20(Suppl 2):S21–S28
  45. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332–338
  46. Jensen MP, Dworkin RH, Gammaitoni AR, et al. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain. 2005;6:98–106
  47. Jensen MP, Gammaitoni AR, Olaleye DO, et al. The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome. J Pain. 2006;7:823–832
  48. Jensen MP, Friedman M, Bonzo D, Richards P. The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain. 2006;22:97–103
  49. Ware JE. SF-36 health survey update. Spine. 2000;25:3130–3139
  50. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  51. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263
  52. Diamond JE, Mueller MJ, Delitto A, Sinacore DR. Reliability of a diabetic foot evaluation. Phys Ther. 1989;69:797–802
  53. Mueller MJ, Diamond JE, Delitto A, Sinacore DR. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther. 1989;69:453–459
  54. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76:68–71
  55. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. College Station, TX: Stata Press; 2005;
  56. Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press; 2003;
  57. Dionne RA, Bartoshuk L, Mogil J, Witter J. Individual responder analyses for pain: does one pain scale fit all?. Trends Pharmacol Sci. 2005;26:125–130
  58. Miaskowski C, Dodd M, West C, et al. The use of a responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain. 2007;129(1–2):55–63
  59. Kiziltan ME, Gunduz A, Kiziltan G, Akalin MA, Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. J Neurol Sci. 2007;258(1–2):75–79
  60. Menz HB, Lord SR, St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Arch Phys Med Rehabil. 2004;85:245–252
  61. Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?. Anesth Analg. 2006;102:1473–1479
  62. Ribu L, Rustoen T, Birkeland K. The prevalence and occurrence of diabetic foot ulcer pain and its impact on health-related quality of life. J Pain. 2006;7:290–299
  63. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norma GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371–383

 This research was supported in part by the Research Service, Department of Veterans Affairs. Additional support was provided by Mr. Thomas C. Barry.

 Drs. Swislocki, Edrington, and Cooper report receiving research support for this study. Mr. Bales and Ms. Orth acknowledge their interest in commercializing the photon stimulation device used in this study. Drs. Saputo, Islas, Miaskowski, Ms. West, and Ms. Weisshaupt have nothing to disclose.

PII: S0885-3924(09)00792-1

doi: 10.1016/j.jpainsymman.2009.05.021

Journal of Pain and Symptom Management
Volume 39, Issue 1 , Pages 88-99 , January 2010

Article Tools

* Image Usage & Resolution